COMBINATION THERAPY FOR COVID-19 VACCINATION

WIPO Patent Application WO/2022/207860

A3

The present invention relates to the combination of a Selective Estrogen Receptor Modulator (SERM) and a COVID-19 vaccine.

JPS61148136	BIS(4-HALOPHENOXY)ETHYL ETHER DERIVATIVE AND PREPARATION THEREOF
JP2005523239	Suppression of exoprotein production using aromatic compounds
WO/2001/032169	AGONISTS SPECIFIC FOR THE PERIPHERAL CANNABINOID RECEPTOR

ALLEGRETTI MARCELLO (IT)
BECCARI ANDREA ROSARIO (IT)
CESTA MARIA CANDIDA (IT)
MAURI ELISABETTA MARIA ESTER (IT)
TALARICO CARMINE (IT)

PCT/EP2022/058688

December 21, 2023

March 31, 2022

Click for automatic bibliography generation  

DOMPE FARM SPA (IT)

A61K31/085; A61K31/138; A61K31/352; A61K31/353; A61K31/4535; A61K31/55; A61K31/565; A61K31/566; A61K31/592; A61K31/593; A61K31/7048; A61K39/215; A61K45/06; A61P31/16

WO2002004956A2

2002-01-17

HONG SUBIN ET AL: "Raloxifene as a treatment option for viral infections", THE JOURNAL OF MICROBIOLOGY, vol. 59, no. 2, 1 February 2021 (2021-02-01), pages 124 - 131, XP037354800, ISSN: 1225-8873, DOI: 10.1007/S12275-021-0617-7
YADI ZHOU ET AL: "Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2", CELL DISCOVERY, vol. 6, no. 1, 16 March 2020 (2020-03-16), XP055726866, DOI: 10.1038/s41421-020-0153-3
CALDERONE ALBA ET AL: "Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option?", FRONTIERS IN PHARMACOLOGY, vol. 11, 15 July 2020 (2020-07-15), XP055828840, Retrieved from the Internet DOI: 10.3389/fphar.2020.01085

MAURI, Elisabetta Maria Ester (IT)

View/Download PDF      PDF Help

Previous Patent: METHODS FOR WELDING COMPONENTS OF BATTERY MODULES

Next Patent: METHODS FOR WELDING COMPONENTS OF BATTERY MODULES